ImageneBio, Inc. (IMA)
(Delayed Data from NSDQ)
$14.67 USD
-0.07 (-0.47%)
Updated Aug 12, 2025 04:00 PM ET
After-Market: $14.54 -0.13 (-0.89%) 7:58 PM ET
2-Buy of 5 2
D Value C Growth B Momentum C VGM
Fundamental Charts
About Dividend Yield (TTM)
ImageneBio, Inc.'s dividend yield currently sits at 0%, which is in-line with the Medical - Biomedical and Genetics industry's yield of 0.00%.
The company's trailing twelve month (TTM) Dividend Yield calculates the indicated annual dividend divided by the stock price. This value is always expressed as a percentage. This is the return on investment that is specifically attributed to the expected dividends that are paid out over a year. Note: investors should not base their investments on the size of the dividend yield alone. Seek attractive dividend yields, but only on top rated stocks with a solid payment history.
IMA 14.67 -0.07(-0.47%)
Will IMA be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for IMA based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for IMA
Wall Street Analysts Believe IMAGENEBIO INC (IMA) Could Rally 695.48%: Here's is How to Trade
IMA: What are Zacks experts saying now?
Zacks Private Portfolio Services
Other News for IMA
ImageneBio Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) | IMA Stock News
Inmagene Biopharmaceuticals Announces Completion of Merger with Ikena Oncology and Concurrent ...
IMAX: Strong Market Position and Growth Potential Justify Buy Rating
Image Resources NL Updates Director’s Securities Holdings
Imax, Helios partner on two new locations in Poland